The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of Mashhad University of Medical Sciences A Faramarzi, J Javan-Noughabi, SS Tabatabaee, AA Najafpoor, ... BMC health services research 21, 1-7, 2021 | 56 | 2021 |
Cost per DALY averted in low, middle-and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds R Daroudi, A Akbari Sari, A Nahvijou, A Faramarzi Cost Effectiveness and Resource Allocation 19, 1-9, 2021 | 45 | 2021 |
Patients’ safety culture status among educational hospitals of Shahid Beheshti University of Medical Sciences in 2011 S Mahfoozpour, E Ainy, F Mobasheri, A Faramarzi Pajoohandeh journal 17 (3), 134-141, 2012 | 37 | 2012 |
Identification determinant factors on willingness to pay for health services in Iran J Javan-Noughabi, Z Kavosi, A Faramarzi, M Khammarnia Health economics review 7, 1-6, 2017 | 34 | 2017 |
Health care expenditure in the Islamic Republic of Iran versus other high spending countries B Khosravi, S Soltani, J Javan-Noughabi, A Faramarzi Medical journal of the Islamic Republic of Iran 31, 71, 2017 | 32 | 2017 |
Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: findings from the global burden of disease study SY Hashemi, V Momenabadi, A Faramarzi, A Kiani Archives of Public Health 78, 1-7, 2020 | 28 | 2020 |
Burden of esophageal cancer in Iran during 1995-2015: Review of findings from the Global Burden of Disease studies H Rahmani, AS Asiabar, S Niakan, SY Hashemi, A Faramarzi, ... Medical journal of the Islamic Republic of Iran 32, 55, 2018 | 16 | 2018 |
Impact of the economic crisis on healthcare resources: A panel data analysis in Eastern Mediterranean countries during 2005 to 2013 AR Ahmad faramarzi , Javad Javan-Noughabi , Ahmad Sadeghi Clinical Epidemiology and Global Health, 2018 | 15* | 2018 |
Socioeconomic status and COVID‐19‐related cases and fatalities in the world: A cross‐sectional ecological study A Faramarzi, J Javan‐Noughabi, SA Mousavi, F Bahrami Asl, ... Health Science Reports 5 (3), e628, 2022 | 14 | 2022 |
The lost productivity cost of premature mortality owing to cancers in iran: evidence from the GLOBOCAN 2012 to 2018 estimates A Nahvijou, R Daroudi, J Javan-Noughabi, H Dehdarirad, A Faramarzi Value in Health Regional Issues 31, 1-9, 2022 | 6 | 2022 |
Burden of esophageal cancer according to world health organization regions: review of findings from the global burden of disease study 2015 A Nahvijou, M Arab, A Faramarzi, SY Hashemi, J Javan-Noughabi Health Scope 8 (3), 2019 | 5 | 2019 |
A study of the evacuation and allocation of hospital beds during the Covid-19 epidemic: a case study in Iran F Soroush, B Nabilou, A Faramarzi, H Yusefzadeh BMC Health Services Research 22 (1), 864, 2022 | 4 | 2022 |
Quality of life in breast cancer patients using neoadjuvant AC (doxorubicin and cyclophosphamide) in comparison with PG (paclitaxel and gemcitabine) therapy A Rezapour, J Javan-Noughabi, A Faramarzi, T Harati Khalilabad, ... Middle East Journal of Cancer 9 (1), 41-47, 2018 | 4 | 2018 |
Investigation of the Relationship between Health and Economic Indicators in Selected Countries, 2004-2011 AA Barfar E , Faramarzi A , KhanijahaniA , Alizadeh S Sadra Med Sci J 2 (4), 349-360, 2014 | 4* | 2014 |
The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis A Faramarzi, S Norouzi, H Dehdarirad, S Aghlmand, H Yusefzadeh, ... Systematic Reviews 13 (1), 68, 2024 | 3 | 2024 |
The economic burden of esophageal cancer in Iran R Daroudi, A Nahvijou, M Arab, A Faramarzi, B Kalaghchi, AA Sari Indian Journal of Cancer 59 (4), 499-506, 2022 | 3 | 2022 |
A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma R Daroudi, A Nahvijou, M Arab, A Faramarzi, B Kalaghchi, AA Sari, ... Cost Effectiveness and Resource Allocation 20 (1), 16, 2022 | 3 | 2022 |
Economic evaluation of treatments for patients with esophageal cancer: a systematic review A Faramarzi, R Daroudi, A Nahvijou, AA Sari, M Arab, B Kalaghchi International Journal of Cancer Management 12 (3), 2019 | 3 | 2019 |
What we should know about health problems in people with intellectual disability: Implications for health policy S Soltani, A Faramarzi, B Khosravi Journal of Research in Medical Sciences 22 (1), 66, 2017 | 2 | 2017 |
Absenteeism Costs Due to COVID-19 and Their Predictors in Non-Hospitalized Patients in Sweden: A Poisson Regression Analysis MA Kisiel, S Lee, H Janols, A Faramarzi International Journal of Environmental Research and Public Health 20 (22), 7052, 2023 | 1 | 2023 |